1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E54BAB1B0C91943F652581410037F915
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/medical-affairs-role-patient-engagement-activities?opendocument
18
19opendocument
2034.229.76.193
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services Medical Affairs Patient Advocacy

Medical Affairs' Role in Patient Engagement Activities

ID: POP-280


Features:

26 Info Graphics

50 Data Graphics

300+ Metrics

24 Narratives

13 Best Practices


Pages: 88


Published: 2017


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
The medical affairs function continues its evolution from a support-only function into an independent role, one that is critical to the success of pharmaceutical companies. With the shift in role, Medical Affairs groups have been charged with patient engagement, bringing together caregivers, payers, health care professionals, and patient advocacy groups in a comprehensive environment centering on patients’ needs.

Best Practices, LLC undertook benchmarking research to produce industry metrics on key aspects of Patient Engagement Programs including collaboration, activities, support, and involvement. In particular, this report delivers benchmarks around Medical Affairs’ role and responsibilities in different patient engagement activities like patient health outcomes, advocacy, education and medication adherence. It also highlights the patient engagement activities/strategies that work best for each group of stakeholders and provides insights into the critical lessons learned and pitfalls.

Responses in this report are presented into two segments: Regional Segment: US-Only and Global and Company-Size Segments: Large Companies and Small Companies


Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care


Companies Profiled:
Abbvie; Actelion; Alkermes; AstraZeneca; Bayer; Biogen; Boehringer Ingelheim; Cipla; Clovis Oncology; Daiichi Sankyo; Genentech; Incyte; Kyowa Kirin; Medivation; Merck; MSD; Novartis; Pfizer; Roche; Sanofi Pasteur; Santen; Shire; Sunovion; Teva Pharmaceutical Industries Ltd; TG Therapeutics; Theravance; Tocagen; UCB Pharma; Vifor Pharma


Study Snapshot

Best Practices, LLC engaged 39 Medical Affairs leaders from 29 biopharmaceutical companies in this research through a benchmarking survey. Almost 85% of the participants are at the level of senior director or above.

Responses are presented into two segments: Regional Segment: US-Only (N=15) and Global (N=16) and Company-Size Segments: Large Companies (N=25) and Small Companies (N=14)

Key topics covered in this report include:

1. Roles and Responsibilities:

  • Patient Health Outcomes
  • Patient Advocacy Groups
  • Patient Education Programs
  • Patient Medication Adherence Programs

2. Collaboration:
  • Medical Affairs Groups
  • Internal/External Frequency
  • Internal/External Effectiveness

3. Patient Engagement Over the Product Lifecycle

Key Findings

  • Own Patient Health Outcomes Programs: Medical Affairs must lead data generation to understand patient needs. Larger companies have greater role in patient outcomes than smaller companies (68% vs. 36%).

  • Engage Patient Advocacy Groups: Collaborate with patient advocacy in early stages. Evolve advocacy services throughout the lifecycle. Structure more formal channels to communicate with advocacy groups.

Table of Contents

I.Executive Summarypgs. 3-7
Research Overviewpg. 3
Participating Companiespg. 4
Segmentationpg. 5
High-Level Recommendationspg. 6
Key Findingspg. 7
II.Lessons Learnedpgs. 8-11
III.Importance and Involvement in Patient Engagement Activitiespgs. 12-34
Patient Health Outcomes Programspgs. 14-18
Patient Advocacy Groupspgs. 19-23
Patient Education Programspgs. 24-28
Patient Medication Adherence Programspgs. 29-33
IV.Collaboration with Internal and External Groupspgs. 35-42
V.Role in the Patient Journeypgs. 43-47
VI.Participant Demographicspgs. 48-52
VII.Appendix A: Voices from the Industrypgs. 53-64
VIII.Appendix B: Segmentation Graphspgs. 65-86
IX.About Best Practices, LLCpgs. 87-88

    List of Charts & Exhibits

    • Critical elements of strong patient engagement
    • Key lessons learned about allocating medical affairs investment to the highest impact areas across the patient journey
    • Pitfalls or stumbling blocks observed for marketing teams as they invest in the patient journey
    • Medical Affairs’ organization’s role with different patient engagement programs
    • Overview of Medical Affairs’ role and the value it places on patient health outcomes activities
    • Importance of different activities in building a successful patient health outcomes program within Medical Affairs group
    • Medical Affairs organization’s role with different patient health outcomes activities
    • Patient health outcomes activities: Role vs. High importance
    • Overview of Medical Affairs’ role and the value it places on patient advocacy activities
    • Importance of different activities in building a successful patient advocacy program within Medical Affairs group
    • Medical Affairs organization’s role with different patient advocacy activities
    • Patient advocacy activities: Role vs. High importance
    • Overview of Medical Affairs’ role and the value it places on patient education
    • Importance of different activities in building a successful patient education program within Medical Affairs group
    • Medical Affairs organization’s role with different patient education activities
    • Patient education activities: Role vs. High importance
    • Overview of Medical Affairs’ role and the value it places on patient medication adherence
    • Importance of different activities in building a successful patient medication adherence program within Medical Affairs group
    • Medical Affairs organization’s role with different patient medication adherence activities
    • Patient medication adherence activities: Role vs. High importance
    • Involvement of specific parts of Medical Affairs organization in patient engagement activities (internal collaboration)
    • Collaboration of Medical Affairs function with internal and external groups on patient engagement activities
    • Frequency of collaboration with key internal groups on patient engagement activities
    • Frequency of collaboration with key external groups on patient engagement activities
    • Effective strategies for internal collaboration
    • Effective strategies for external collaboration
    • Effective approaches in supporting patients at the early stage of their disease
    • Effective approaches in supporting patients at the late-stage of their disease